Ultimovacs Company
Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer.
Technology:
Peptides and Proteins
Industry:
Peptides and Proteins
Headquarters:
Oslo, Oslo, Norway
Founded Date:
2011-01-01
Employees Number:
11-50
Funding Status:
IPO
Total Funding:
32279700
Last Funding Date:
2021-10-26
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership